Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2111383 Target Snapshot

Serotonin receptor 2a and 2c (5HT2A and 5HT2C) · SELECTIVITY GROUP · Rattus norvegicus

139Compounds
17Assays
0Approved Drugs
26.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P08909. Use UniProt P08909 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P08909 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Serotonin receptor 2a and 2c (5HT2A and 5HT2C) as ChEMBL target CHEMBL2111383, mapped to UniProt P08909. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Serotonin receptor 2a and 2c (5HT2A and 5HT2C)
SELECTIVITY GROUP · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL2111383
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P08909
5-hydroxytryptamine receptor 2C
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Serotonin receptor 2a and 2c (5HT2A and 5HT2C) is the right protein anchor across sources, using UniProt P08909 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 2C
UniProt AccessionP08909
Component TypeProtein
Sequence Length460 aa

5-hydroxytryptamine receptor 2C

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Serotonin receptor 2a and 2c (5HT2A and 5HT2C), mapped to UniProt P08909. ChEMBL maps the protein component as 5-hydroxytryptamine receptor 2C. Sequence length is 460 aa.

Mapped IDP08909
Review nameSerotonin receptor 2a and 2c (5HT2A and 5HT2C)
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

3
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC501.0
KI24.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL69700 9.4 Ki 0.4 Preclinical
CHEMBL267930 9.3 Ki 0.5 Clinical
CHEMBL6616 9.15 Ki 0.7 Preclinical
CHEMBL136354 8.96 Ki 1.1 Preclinical
CHEMBL51 8.92 Ki 1.2 Clinical
CHEMBL51 8.86 Kd 1.37 Clinical
CHEMBL6620 8.82 Ki 1.5 Preclinical
CHEMBL338297 8.72 Ki 1.9 Preclinical
CHEMBL18786 8.42 Ki 3.8 Clinical
CHEMBL39 8.21 Ki 6.1 Clinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
1
6.0
0
6.5
3
7.0
3
7.5
4
8.0
11
8.5
3
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

17
Total Assays
10
Tested Compounds
1
Assay Types
Binding — 17 assays, 10 compounds
BAO Format Assays Compounds Avg pChEMBL
protein format 10 4 8.2
tissue-based format 7 6 8.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine